Guangwei Du

ORCID: 0000-0002-8267-0301
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • Advanced Neuroimaging Techniques and Applications
  • Heavy Metal Exposure and Toxicity
  • Trace Elements in Health
  • Genetic Neurodegenerative Diseases
  • RNA regulation and disease
  • Nuclear Receptors and Signaling
  • Traumatic Brain Injury Research
  • Cerebrospinal fluid and hydrocephalus
  • Balance, Gait, and Falls Prevention
  • Botulinum Toxin and Related Neurological Disorders
  • Radiomics and Machine Learning in Medical Imaging
  • Medical Imaging Techniques and Applications
  • Autism Spectrum Disorder Research
  • Medical Image Segmentation Techniques
  • Cerebral Palsy and Movement Disorders
  • Transcranial Magnetic Stimulation Studies
  • Olfactory and Sensory Function Studies
  • Viral Infections and Immunology Research
  • Electrical and Bioimpedance Tomography
  • Anatomy and Medical Technology
  • Neurobiology of Language and Bilingualism
  • RNA Research and Splicing
  • Neurological Disorders and Treatments

Pennsylvania State University
2016-2025

Penn State Milton S. Hershey Medical Center
2015-2024

Dong-A University
2023

Hershey (United States)
2016-2019

Capital Medical University
2004-2018

Siemens (China)
2008

Institute of Microbiology
2001

Recent magnetic resonance imaging studies suggest an increased transverse relaxation rate and reduced diffusion tensor fractional anisotropy values in the substantia nigra Parkinson's disease. The changes may reflect different aspects of disease-related pathological processes (ie, tissue iron deposition microstructure disorganization). This study investigated combined High-resolution (T2-weighted, T2*, imaging) were obtained from 16 disease patients controls. Bilateral nigras delineated...

10.1002/mds.23643 article EN Movement Disorders 2011-05-26

Parkinson's disease (PD) is marked pathologically by dopamine neuron loss and iron overload in the substantia nigra pars compacta. Midbrain content reported to be increased PD based on magnetic resonance imaging (MRI) R2* changes. Because quantitative susceptibility mapping a novel MRI approach measure content, we compared it with for assessing midbrain changes PD.Quantitative maps were obtained from 47 patients healthy controls. values analyzed using both voxel-based region-of-interest...

10.1002/mds.26417 article EN Movement Disorders 2015-09-12

Automated segmenting and labeling of individual brain anatomical regions, in MRI are challenging, due to the issue structural variability. Although atlas-based segmentation has shown its potential for both tissue structure segmentation, inherent natural variability as well disease-related changes MR appearance, a single atlas image is often inappropriate represent full population datasets processed given neuroimaging study. As an alternative case use multiple atlases alongside label fusion...

10.3389/fninf.2014.00007 article EN cc-by Frontiers in Neuroinformatics 2014-01-01

Abstract Background The objective of this study was to determine whether neurotoxic kynurenine metabolites, induced by inflammation, in plasma and cerebrospinal fluid (CSF) are associated with symptom severity nigral pathology Parkinson's disease (PD). Methods Clinical MRI data were obtained from 97 PD 89 controls. We used ultra‐performance liquid chromatography quantify metabolites high‐sensitivity multiplex assays inflammation CSF. evaluated group‐wise differences as well associations...

10.1002/mds.28202 article EN cc-by Movement Disorders 2020-07-25

The pattern of dopamine cell loss in Parkinson's disease (PD) is known to be prominent the ventrolateral and caudal substantia nigra (SN), but less severe dorsal rostral region. Both diffusion tensor imaging (DTI) R2* relaxometry SN have been reported as potential markers for PD, their relative ability mark progression differences pathophysiological bases remains unclear. High-resolution T2-weighted, R2*, DTI were obtained from 28 controls 40 PD subjects [15 early stage [disease duration ≤1...

10.1002/mds.25182 article EN Movement Disorders 2012-09-24

Abstract Background: Susceptibility MRI may capture Parkinson's disease‐related pathology. This study delineated longitudinal changes in different substantia nigra regions. Methods: Seventy‐two PD patients and 62 controls were studied at both baseline after 18 months with MRI. R2* quantitative susceptibility mapping values from the pars compacta reticulata calculated. Mixed‐effects models compared or subgroups having disease durations: early (<1 year), middle (<5 years, middle‐stage...

10.1002/mds.27318 article EN publisher-specific-oa Movement Disorders 2018-05-14

Abstract Background Imaging markers that are sensitive to parkinsonism across multiple sites critically needed for clinical trials. The objective of this study was evaluate changes in the substantia nigra using single‐ and bi‐tensor models diffusion magnetic resonance imaging PD, MSA, PSP. Methods cohort (n = 425) included 107 healthy controls 184 63 71 PSP patients from 3 movement disorder centers. Bi‐tensor free water, free‐water‐corrected fractional anisotropy, mean diffusivity,...

10.1002/mds.27100 article EN Movement Disorders 2017-07-17

ABSTRACT Background Circulating cholesterol levels have been linked to PD, but not directly brain physiology. Objective To assess whether metabolism is related PD. Methods Sixty PD patients and 64 controls were recruited from an academic movement disorder clinic (2009–2012). Thirty‐five 33 returned approximately 36 months later. Fasting plasma (S) 24‐OH‐cholesterol (brain‐derived metabolite) 27‐OH‐cholesterol (peripheral quantified. Odds ratios for derived logistic regression models,...

10.1002/mds.27609 article EN Movement Disorders 2019-01-25

ABSTRACT Background Deposition and spreading of misfolded proteins (α‐synuclein tau) have been linked to Parkinson's disease cognitive dysfunction. The glymphatic system may play an important role in the clearance these toxic via cerebrospinal fluid (CSF) flow through perivascular interstitial spaces. Recent studies discovered that sleep‐dependent global brain activity is coupled CSF flow, which reflect function. Objective objective this current study was determine if decoupling activity–CSF...

10.1002/mds.28643 article EN Movement Disorders 2021-05-17

Abstract Background Higher nigral iron has been reported in Parkinson's disease (PD). Objective The aim is to understand the dynamics of accumulation PD and its association with drug treatment. Methods Susceptibility magnetic resonance imaging data were obtained from 79 controls 18 drug‐naive (PD DN ) 87 drug‐treated DT patients. Regional brain basal ganglia cerebellar structures was estimated using quantitative susceptibility mapping. Nigral compared between subgroups defined by duration...

10.1002/mds.29062 article EN Movement Disorders 2022-05-25

Background: Reduced arm swing amplitude, symmetry, and coordination during gait have been reported in Parkinson's disease (PD), but the relationship between dopaminergic depletion these upper limb changes remains unclear. Objective: We aimed

10.3233/jpd-140447 article EN Journal of Parkinson s Disease 2015-01-01

ABSTRACT Background Olfactory dysfunction is often associated with Parkinson's disease (PD) and can precede characteristic motor symptoms by several years. Olfactory‐related cortical atrophy has been reported in PD, although the extent association between olfactory have controversial. The present study examined whether gray matter (GM) volume brain regions subserving primary secondary processing. Methods High‐resolution T1‐weighted MRIs were acquired from 40 PD without dementia matched...

10.1002/mds.25829 article EN Movement Disorders 2014-01-30

<h3>Objective:</h3> Nigrostriatal terminal losses are known to progress most rapidly in early-stage Parkinson disease (PD) and then plateau, whereas cortical pathology continues may provide a better marker of PD progression later stages. We investigated gyrification indices patients with different durations PD, since folding capture complex processes involving transverse forces neuronal sheets or underlying axonal connectivity. <h3>Methods:</h3> Longitudinal cohort structural MRI were...

10.1212/wnl.0000000000002492 article EN Neurology 2016-02-18

Importance Magnetic resonance imaging (MRI) paired with appropriate disease-specific machine learning holds promise for the clinical differentiation of Parkinson disease (PD), multiple system atrophy (MSA) parkinsonian variant, and progressive supranuclear palsy (PSP). A prospective study is needed to test whether approach meets primary end points be considered in a diagnostic workup. Objective To assess discriminative performance Automated Imaging Differentiation Parkinsonism (AIDP) using...

10.1001/jamaneurol.2025.0112 article EN cc-by JAMA Neurology 2025-03-17

Welding-generated metallic fumes contain a substantial amount of manganese (Mn), making welders susceptible to Mn toxicity. Although overt toxicity manifests as type parkinsonism, the consequences chronic, low-level exposure are unknown. To explore region-specific accumulation and its potential functional at subclinical levels exposure, we studied seven without obvious neurological deficits age- gender-matched controls. for was estimated by an occupational questionnaire. High-resolution...

10.1093/toxsci/kfr033 article EN Toxicological Sciences 2011-02-09

Although the essential element manganese (Mn) is neurotoxic at high doses, effects of lower exposure are unclear.MRI T1-weighted (TIW) imaging has been used to estimate brain Mn via pallidal index (PI), defined as T1W intensity ratio in globus pallidus (GP) versus frontal white matter (FWM).PI may not, however, be sensitive GP because also accumulate FWM.This study explored: (1) whether T1 relaxation rate (R1) could quantify accumulation more sensitively; and (2) dose-response relationship...

10.1093/toxsci/kfv088 article EN Toxicological Sciences 2015-05-07

ABSTRACT Background : Parkinsonisms are neurodegenerative disorders characterized pathologically by α‐synuclein‐positive (e.g., PD, diffuse Lewy body disease, and MSA) and/or tau‐positive PSP, cortical basal degeneration) pathology. Using R2* quantitative susceptibility mapping, changes have been reported in the midbrain of living parkinsonian patients, although exact underlying pathology these alterations is unknown. Objective The current study investigated pathological correlates MRI...

10.1002/mds.27381 article EN Movement Disorders 2018-05-14

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized clinically by motor dysfunction (bradykinesia, rigidity, tremor, and postural instability), pathologically the loss of dopaminergic neurons in substantia nigra basal ganglia. Growing literature supports that cognitive deficits may also be present PD, even non-demented patients. Gray matter (GM) atrophy has been reported PD related to decline. This study investigated cortical thickness subjects elucidated its...

10.1109/tcbb.2015.2465951 article EN IEEE/ACM Transactions on Computational Biology and Bioinformatics 2015-08-20
Coming Soon ...